Health In Tech, Inc. (HIT)
NASDAQ: HIT · Real-Time Price · USD
1.110
+0.070 (6.73%)
At close: Jul 31, 2026, 4:00 PM EDT
1.090
-0.020 (-1.80%)
After-hours: Jul 31, 2026, 4:11 PM EDT
Health In Tech Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Health In Tech stock has a consensus rating of "Buy" and an average price target of $4.03. The average 1-year stock price forecast is 263.06% higher than the current stock price, while the lowest is $4.00 (+260.36%) and the highest is $4.10 (+269.37%).
Price Target: $4.03 (+263.06%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on May 14, 2026.
Analyst Ratings
The average analyst rating for Health In Tech stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Reiterates $4 | Buy | Reiterates | $4 | +260.36% | May 14, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $4 | Buy | Reiterates | $4 | +260.36% | May 14, 2026 |
Financial Forecast
Revenue This Year
46.81M
from 33.33M
Increased by 40.45%
Revenue Next Year
78.52M
from 46.81M
Increased by 67.75%
EPS This Year
-0.06
from 0.02
EPS Next Year
0.14
from -0.06
EPS and Forward PE are based on non-GAAP adjusted numbers.